Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

20.70
Delayed Data
As of 3:59pm ET
 -0.30 / -1.43%
Today’s Change
16.40
Today|||52-Week Range
40.57
+10.11%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 25.50, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +23.19% increase from the last price of 20.70.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.08
Sales
$137.9M
Reporting Date
Feb 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 298.27%
 
 
 
 
 
 
Growthannually -80.90%
 
 
 
 
 
 

Sales

Growthquarterly 1.70%
 
 
 
 
 
 
Growthannually 4.99%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.